Researchers at the University of North Carolina found that a once-weekly injection of Ozempic could cut cravings at its lowest dose level.

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

A Phase 3 clinical trial found that injections of the semaglutide medication once weekly reduced the risk of kidney disease ... "This really means something to the patients," Gough told CNN. "The ...

In interviews with Reuters, five patients who participated in the trial that reported in December - or are part of a separate late-stage study - said the weekly injection helped them shed pounds ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily ...

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

“There are medications that work — but they are priced for profits, not patients ... the company’s GLP-1 injections. The weekly treatment contains off-brand semaglutide — the ...

Novo Nordisk markets its semaglutide medicines as Ozempic pre-filled pens and Rybelsus oral tablets for type II diabetes (T2D) and Wegovy injections ... and safety of once weekly, subcutaneous ...